Table 3.
Samples | Peripartum maternal antibiotic therapy | Mode of delivery | Gestational age | Genotype | ||||
---|---|---|---|---|---|---|---|---|
Spacer1 | Spacer2 | Spacer 3 | Spacer 4 | Spacer type* | ||||
1 | Yes | Cesarean | 26 | X | X | X | X | 1 |
2 | No | Cesarean | 32 | X | X | X | X | 1 |
3 | No | Vaginal delivery | 30 | X | X | X | X | 1 |
4 | No | Vaginal delivery | 30 | X | X | X | X | 1 |
5 | Yes | Vaginal delivery | 30 | X | X | X | X | 1 |
6 | No | Cesarean | 28 | X | X | X | 2 | |
7 | Yes | Cesarean | 27 | X | X | X | X | 1 |
8 | Yes | Cesarean | 30 | X | X | X | X | 1 |
9 | No | Cesarean | 30 | X | X | X | X | 1 |
10 | No | Cesarean | 31 | X | X | X | X | 1 |
11 | No | Cesarean | 32 | X | X | X | X | 1 |
12 | No | Cesarean | 29 | X | X | X | X | 1 |
13 | No | Cesarean | 29 | X | X | X | X | 1 |
14 | No | Cesarean | 32 | X | X | X | X | 1 |
15 | No | Cesarean | 32 | X | X | X | X | 1 |
16 | No | Cesarean | 25 | X | X | X | X | 1 |
17 | No | Cesarean | 30 | X | X | X | X | 1 |
18 | No | Cesarean | 30 | X | X | X | X | 1 |
19 | No | Cesarean | 27 | X | X | X | X | 1 |
20 | No | Vaginal delivery | 25 | X | X | X | X | 1 |
21 | No | Cesarean | 31 | X | X | X | X | 1 |
22 | No | Cesarean | 31 | X | X | X | X | 1 |
23 | Yes | Vaginal delivery | 32 | X | X | X | X | 1 |
*Spacer type was determined according to references (Grine et al., 2017; Guindo et al., 2021; Nkamga et al., 2015).